- Home
- / Luye Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Luye Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3
2024-10-29
Market Capitalization
$10.9 B
2024-10-29
Revenue
¥6.3 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.2B | 6.4B | 5.5B | 5.2B | 6.0B | 6.1B | 6.1B | 6.3B |
| Cost of goods sold | 858.4M | 1.1B | 1.1B | 1.3B | 1.2B | 1.2B | 1.2B | 1.3B |
| Gross profit | 4.4B | 5.4B | 4.6B | 4.0B | 4.9B | 5.1B | 5.0B | 5.1B |
| Gross profit margin, % | 85.2% | 85.1% | 83.5% | 77.2% | 82.3% | 83.8% | 82.8% | 80.2% |
| Operating expense total | 2.6B | 3.2B | 2.9B | 3.3B | 3.4B | 3.3B | 2.9B | 3.0B |
| Depreciation and amortization | 310.9M | 455.7M | 510.9M | 582.0M | 671.3M | 701.9M | 790.7M | 839.5M |
| EBITDA | 1.8B | 2.2B | 1.7B | 744.7M | 1.5B | 1.8B | 2.1B | 2.1B |
| EBITDA margin, % | 35.4% | 34.6% | 30.7% | 14.3% | 25.6% | 29.6% | 34.4% | 32.8% |
| EBIT | 1.5B | 1.8B | 1.2B | 174.1M | 857.7M | 1.1B | 1.3B | 1.4B |
| EBIT margin, % | 29.4% | 27.6% | 21.5% | 3.3% | 14.3% | 18.2% | 21.7% | 21.9% |
| Interest income | 62.7M | 98.8M | 110.4M | 102.0M | 88.7M | 117.1M | 84.4M | 96.1M |
| Interest expense | 170.6M | 295.5M | 424.0M | 399.5M | 471.8M | 675.5M | 561.8M | 686.6M |
| Pre tax profit | 1.5B | 1.6B | 942.2M | (74.6M) | 669.8M | 700.1M | 839.2M | 944.6M |
| Income tax expense | 167.5M | 279.8M | 238.9M | 70.2M | 86.5M | 161.0M | 194.2M | 239.0M |
| Net Income | 1.3B | 1.4B | 703.3M | (144.8M) | 583.3M | 539.1M | 645.0M | 705.7M |